Department of Intensive care, Erasmus Medical Center, Rotterdam, the Netherlands.
Department of Intensive care, Ikazia Hospital, Rotterdam, the Netherlands.
PLoS One. 2018 Jun 6;13(6):e0197301. doi: 10.1371/journal.pone.0197301. eCollection 2018.
Acute kidney injury (AKI) requiring renal replacement therapy (RRT) is associated with high mortality. The creatinine-based stage of AKI is considered when deciding to start or delay RRT. However, creatinine is not only determined by renal function (excretion), but also by dilution (fluid balance) and creatinine generation (muscle mass). The aim of this study was to explore whether fluid balance-adjusted creatinine at initiation of RRT is related to 28-day mortality independent of other markers of AKI, surrogates of muscle mass and severity of disease.
We performed a post-hoc analysis on data from the multicentre CASH trial comparing citrate to heparin anticoagulation during continuous venovenous hemofiltration (CVVH). To determine whether fluid balance-adjusted creatinine was associated with 28-day mortality, we performed a logistic regression analysis adjusting for confounders of creatinine generation (age, gender, body weight), other markers of AKI (creatinine, urine output) and severity of disease.
Of the 139 patients, 32 patients were excluded. Of the 107 included patients, 36 died at 28 days (34%). Non-survivors were older, had higher APACHE II and inclusion SOFA scores, lower pH and bicarbonate, lower creatinine and fluid balance-adjusted creatinine at CVVH initiation. In multivariate analysis lower fluid balance-adjusted creatinine (OR 0.996, 95% CI 0.993-0.999, p = 0.019), but not unadjusted creatinine, remained associated with 28-day mortality together with bicarbonate (OR 0.869, 95% CI 0.769-0.982, P = 0.024), while the APACHE II score non-significantly contributed to the model.
In this post-hoc analysis of a multicentre trial, low fluid balance-adjusted creatinine at CVVH initiation was associated with 28-day mortality, independent of other markers of AKI, organ failure, and surrogates of muscle mass, while unadjusted creatinine was not. More tools are needed for better understanding of the complex determinants of "AKI classification", "CVVH initiation" and their relation with mortality, fluid balance is only one.
需要肾脏替代治疗(RRT)的急性肾损伤(AKI)与高死亡率相关。在决定开始或延迟 RRT 时,会考虑基于肌酸酐的 AKI 分期。然而,肌酸酐不仅由肾功能(排泄)决定,还由稀释(液体平衡)和肌酸酐生成(肌肉质量)决定。本研究的目的是探讨 RRT 开始时的液体平衡调整后的肌酸酐是否与 28 天死亡率相关,而与其他 AKI 标志物、肌肉质量的替代指标和疾病严重程度无关。
我们对比较柠檬酸与肝素抗凝在连续静脉-静脉血液滤过(CVVH)中的多中心 CASH 试验的数据进行了事后分析。为了确定液体平衡调整后的肌酸酐是否与 28 天死亡率相关,我们进行了逻辑回归分析,调整了肌酸酐生成的混杂因素(年龄、性别、体重)、其他 AKI 标志物(肌酸酐、尿量)和疾病严重程度。
在 139 名患者中,有 32 名患者被排除在外。在纳入的 107 名患者中,有 36 名在 28 天内死亡(34%)。幸存者年龄较大,APACHE II 和纳入 SOFA 评分较高,pH 值和碳酸氢盐较低,CVVH 开始时的肌酸酐和液体平衡调整后的肌酸酐较低。在多变量分析中,较低的液体平衡调整后的肌酸酐(OR 0.996,95%CI 0.993-0.999,p = 0.019),而不是未经调整的肌酸酐,与 28 天死亡率相关,与碳酸氢盐相关(OR 0.869,95%CI 0.769-0.982,P = 0.024),而 APACHE II 评分则与模型无关。
在这项多中心试验的事后分析中,CVVH 开始时的低液体平衡调整后的肌酸酐与 28 天死亡率相关,与其他 AKI 标志物、器官衰竭和肌肉质量的替代指标无关,而未经调整的肌酸酐则无关。需要更多的工具来更好地理解“AKI 分类”、“CVVH 开始”及其与死亡率的关系的复杂决定因素,液体平衡只是其中之一。